MX356518B - Producción de nanopartículas encapsuladas en fracciones de alto volumen. - Google Patents
Producción de nanopartículas encapsuladas en fracciones de alto volumen.Info
- Publication number
- MX356518B MX356518B MX2011011230A MX2011011230A MX356518B MX 356518 B MX356518 B MX 356518B MX 2011011230 A MX2011011230 A MX 2011011230A MX 2011011230 A MX2011011230 A MX 2011011230A MX 356518 B MX356518 B MX 356518B
- Authority
- MX
- Mexico
- Prior art keywords
- production
- high volume
- volume fractions
- biologically active
- encapsulated nanoparticles
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title 1
- 239000011149 active material Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000009837 dry grinding Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/18—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
- B02C17/14—Mills in which the charge to be ground is turned over by movements of the container other than by rotating, e.g. by swinging, vibrating, tilting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
- B02C17/18—Details
- B02C17/20—Disintegrating members
Abstract
La presente invención se refiere a métodos para la producción de partículas de un material biológicamente activo al usar procesos de molienda en seco así como a composiciones que comprenden tales materiales, medicamentos producidos al usar dichos materiales biológicamente activos en forma de partículas y/o composiciones, y a métodos de tratamiento de un animal, incluyendo el hombre, al usar una cantidad terapéuticamente efectiva de dichos materiales biológicamente activos administrados por medio de dichos medicamentos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17227809P | 2009-04-24 | 2009-04-24 | |
AU2009901744A AU2009901744A0 (en) | 2009-04-24 | Production of Encapsulated Nanoparticles at High Volume Fractions | |
PCT/AU2010/000464 WO2010121320A1 (en) | 2009-04-24 | 2010-04-23 | Production of encapsulated nanoparticles at high volume fractions |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011011230A MX2011011230A (es) | 2012-02-08 |
MX356518B true MX356518B (es) | 2018-05-31 |
Family
ID=43010603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011011230A MX356518B (es) | 2009-04-24 | 2010-04-23 | Producción de nanopartículas encapsuladas en fracciones de alto volumen. |
Country Status (21)
Country | Link |
---|---|
US (5) | US20120165410A1 (es) |
EP (2) | EP2421509B1 (es) |
JP (2) | JP6141012B2 (es) |
KR (3) | KR101743896B1 (es) |
CN (2) | CN102438593A (es) |
AP (1) | AP3138A (es) |
AU (1) | AU2010239159C1 (es) |
BR (1) | BRPI1014878A2 (es) |
CA (1) | CA2759102A1 (es) |
CO (1) | CO6470805A2 (es) |
DK (1) | DK2421509T3 (es) |
EA (1) | EA201171279A1 (es) |
IL (2) | IL254370B2 (es) |
MA (1) | MA33297B1 (es) |
MX (1) | MX356518B (es) |
MY (1) | MY159098A (es) |
NZ (1) | NZ595973A (es) |
SG (1) | SG175309A1 (es) |
UA (1) | UA110322C2 (es) |
WO (1) | WO2010121320A1 (es) |
ZA (1) | ZA201108651B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5508003B2 (ja) | 2006-06-30 | 2014-05-28 | アイスイティカ ピーティーワイ リミテッド | ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法 |
BRPI1014276B8 (pt) * | 2009-04-24 | 2021-05-25 | Iceutica Pty Ltd | produção de nanopartículas encapsuladas em escala comercial |
WO2010121323A1 (en) * | 2009-04-24 | 2010-10-28 | Iceutica Pty Ltd | Method for the production of commercial nanoparticle and microparticle powders |
BRPI1014275B8 (pt) | 2009-04-24 | 2021-05-25 | Iceutica Pty Ltd | composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos |
CN102438592B (zh) * | 2009-04-24 | 2016-09-14 | 伊休蒂卡有限公司 | 甲氧萘普酸的剂型 |
NZ595903A (en) * | 2009-04-24 | 2014-03-28 | Iceutica Pty Ltd | A novel formulation of metaxalone |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
US20120115799A1 (en) * | 2010-05-11 | 2012-05-10 | Wenhua Wang | Pharmaceutical formulations |
EA028946B1 (ru) | 2011-04-13 | 2018-01-31 | Янссен Фармацевтика Нв | Способ получения соединений для применения в качестве ингибиторов sglt2 |
EP2712628B1 (en) | 2012-09-28 | 2016-08-10 | Shanta Banerjee | Composition for use as a medicine or dietetic food, in particular in the prevention and/or treatment of Diabetes and diabetes associated diseases |
CN105121023B (zh) * | 2013-02-28 | 2017-08-25 | 太阳化学公司 | 用于在液体分散液中制造研磨的固体的装置和连续方法 |
SG10201800491RA (en) * | 2013-07-22 | 2018-03-28 | Iceutica Inc | Formulation of metaxalone |
US20150157646A1 (en) | 2013-09-27 | 2015-06-11 | Iceutica Inc. | Abiraterone Steroid Formulation |
ES2542088B1 (es) * | 2014-01-29 | 2016-05-05 | Enoc Solutions, S.L. | Composición de azufre liposomado |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
CN104174468B (zh) * | 2014-08-27 | 2016-06-15 | 上海延安药业有限公司 | 粘稠性药物锆珠研磨方法 |
JP2018515416A (ja) * | 2015-05-20 | 2018-06-14 | ユニヴェルシテ ピエール エ マリ キュリ(パリ 6) | Bp、b12p2およびそれらの混合物の、特にナノ粉末としての製造のためのメカノケミカル方法 |
US9730867B2 (en) | 2016-01-06 | 2017-08-15 | The Procter & Gamble Company | Methods of forming a slurry with microcapsules formed from phosphate esters |
US9732303B2 (en) | 2016-01-06 | 2017-08-15 | The Procter & Gamble Company | Microcapsules formed from phosphate esters and compositions containing same |
US10154947B2 (en) | 2016-01-06 | 2018-12-18 | The Procter & Gamble Company | Antiperspirant composition |
US9975255B1 (en) * | 2016-12-15 | 2018-05-22 | Jabil Inc. | Apparatus, system and method for providing a conformable vacuum cup for an end effector |
CN107417640B (zh) * | 2017-02-22 | 2019-03-26 | 浙江大学 | 纳米噻唑锌的制备方法 |
CN107198677B (zh) * | 2017-05-25 | 2021-07-09 | 长春金赛药业有限责任公司 | 黄体酮混悬型长效注射剂及其制备方法和黄体酮混悬注射粉针 |
KR102105872B1 (ko) * | 2018-05-18 | 2020-04-29 | 강원대학교산학협력단 | 열용융압출법을 이용하여 제조된 구리 나노콜로이드 분산체 및 이의 용도 |
WO2019238261A1 (en) | 2018-06-15 | 2019-12-19 | Ramirez Rios Liliana Patricia | METAL COMPLEXES OF β-DIKETONES AND/OR POLYPHENOLS BY GREEN CHEMISTRY, PREPARATION METHOD THEREOF, SUNSCREEN THEREOF, SKIN OR HAIR TONE CONCEALER THEREOF, HAIR DYEING THEREOF AND OTHER USES THEREOF |
CN108904506A (zh) * | 2018-07-27 | 2018-11-30 | 河南大华生物技术有限公司 | 一种地克珠利纳米粉末及其制备方法 |
CN108902480A (zh) * | 2018-07-27 | 2018-11-30 | 河南大华生物技术有限公司 | 一种提高饲料中微量添加物均匀度和生物利用度的方法 |
AR116501A1 (es) * | 2018-09-25 | 2021-05-12 | Tolmar Int Ltd | Sistema de suministro de polímero líquido para administración extendida de drogas |
KR102359021B1 (ko) * | 2019-07-29 | 2022-02-07 | (주)케나프 | 가용성 플라보노이드 및 폴리페놀의 함량을 증진시키는 케나프 종자의 가공방법 및 이의 가공물 |
CN113133970A (zh) * | 2020-01-17 | 2021-07-20 | 美国琛蓝营养制品股份有限公司 | 一种姜黄素复合物及其制备方法和检测方法 |
CN112674302A (zh) * | 2021-01-07 | 2021-04-20 | 贵州山珍宝绿色科技开发有限公司 | 一种百香果刺梨果糕的制备方法 |
CA3210442A1 (en) * | 2021-03-03 | 2022-09-09 | Jason M. Perry | Dihydroergotamine dry powder formulations and methods of use |
CN113729011A (zh) * | 2021-07-30 | 2021-12-03 | 安徽瑞然生物药肥科技有限公司 | 草甘膦可溶粒剂及其生产方法 |
WO2023080189A1 (ja) * | 2021-11-04 | 2023-05-11 | 興和株式会社 | 医薬品 |
TW202320776A (zh) * | 2021-11-04 | 2023-06-01 | 日商興和股份有限公司 | 膠囊劑 |
CN114210995B (zh) * | 2021-12-17 | 2023-03-10 | 浙江大学 | 一种利用牛蒡根提取液制备纳米银颗粒的方法、产品和应用 |
EP4209212A1 (en) * | 2022-01-05 | 2023-07-12 | HWI pharma services GmbH | Aqueous composition comprising avermectins |
CN114671704B (zh) * | 2022-04-22 | 2023-04-18 | 广州粤瓷新材料有限公司 | 一种低膨胀多孔堇青石及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU660852B2 (en) * | 1992-11-25 | 1995-07-06 | Elan Pharma International Limited | Method of grinding pharmaceutical substances |
US5500331A (en) | 1994-05-25 | 1996-03-19 | Eastman Kodak Company | Comminution with small particle milling media |
US5478705A (en) | 1994-05-25 | 1995-12-26 | Eastman Kodak Company | Milling a compound useful in imaging elements using polymeric milling media |
JP4117811B2 (ja) * | 1997-04-22 | 2008-07-16 | 日本化薬株式会社 | フルタミド製剤及びその製法 |
SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
JP4763957B2 (ja) * | 2000-05-10 | 2011-08-31 | オバン・エナジー・リミテッド | メディアミリング |
ATE424811T1 (de) | 2000-08-31 | 2009-03-15 | Jagotec Ag | Gemahlene partikel |
ATE382335T1 (de) * | 2000-11-30 | 2008-01-15 | Vectura Ltd | Verfahren zur vorbereitung von mikropartikeln zur verwendung in pharmazeutischen zusammensetzungen zur inhalation |
JP2004099442A (ja) * | 2002-09-04 | 2004-04-02 | Nisshin Pharma Inc | 難溶性薬物含有製剤およびその製造方法 |
KR20060024927A (ko) * | 2004-09-15 | 2006-03-20 | 씨제이 주식회사 | 기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법 |
US20090028948A1 (en) * | 2004-12-31 | 2009-01-29 | Iceutica Pty Ltd | Nanoparticle composition and methods of synthesis thereof |
PL1848866T3 (pl) | 2005-02-08 | 2017-10-31 | Mb Couplers Pty Ltd | Pręt zbrojeniowy |
EP1973523A2 (en) * | 2005-12-15 | 2008-10-01 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
JP2007169226A (ja) * | 2005-12-22 | 2007-07-05 | Ono Pharmaceut Co Ltd | 固体分散体 |
US8420122B2 (en) * | 2006-04-28 | 2013-04-16 | Merck Sharp & Dohme Corp. | Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
US8808751B2 (en) * | 2006-06-30 | 2014-08-19 | Iceutica Pty Ltd. | Methods for the preparation of biologically active compounds in nanoparticulate form |
JP5508003B2 (ja) * | 2006-06-30 | 2014-05-28 | アイスイティカ ピーティーワイ リミテッド | ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法 |
PE20081891A1 (es) * | 2007-03-22 | 2008-12-27 | Opko Health Inc | Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas |
US8568696B2 (en) * | 2008-08-06 | 2013-10-29 | Indiana Nanotech Llc | Grinding method for the manipulation or preservation of calcium phosphate hybrid properties |
KR101679522B1 (ko) * | 2009-04-24 | 2016-11-24 | 아이슈티카 피티와이 리미티드 | 생물학적 활성 물질의 용해 프로파일 개선방법 |
BRPI1014276B8 (pt) * | 2009-04-24 | 2021-05-25 | Iceutica Pty Ltd | produção de nanopartículas encapsuladas em escala comercial |
-
2010
- 2010-04-23 EP EP10766513.5A patent/EP2421509B1/en active Active
- 2010-04-23 SG SG2011077351A patent/SG175309A1/en unknown
- 2010-04-23 KR KR1020167033129A patent/KR101743896B1/ko active IP Right Grant
- 2010-04-23 KR KR20157006503A patent/KR20150032759A/ko active Application Filing
- 2010-04-23 US US13/265,914 patent/US20120165410A1/en not_active Abandoned
- 2010-04-23 KR KR1020117027882A patent/KR101848766B1/ko active IP Right Grant
- 2010-04-23 BR BRPI1014878A patent/BRPI1014878A2/pt not_active Application Discontinuation
- 2010-04-23 DK DK10766513.5T patent/DK2421509T3/en active
- 2010-04-23 MX MX2011011230A patent/MX356518B/es active IP Right Grant
- 2010-04-23 UA UAA201113809A patent/UA110322C2/uk unknown
- 2010-04-23 MA MA34384A patent/MA33297B1/fr unknown
- 2010-04-23 AP AP2011005993A patent/AP3138A/xx active
- 2010-04-23 CN CN2010800180112A patent/CN102438593A/zh active Pending
- 2010-04-23 EP EP17202841.7A patent/EP3338766A1/en not_active Withdrawn
- 2010-04-23 CA CA2759102A patent/CA2759102A1/en not_active Abandoned
- 2010-04-23 NZ NZ595973A patent/NZ595973A/en unknown
- 2010-04-23 EA EA201171279A patent/EA201171279A1/ru unknown
- 2010-04-23 WO PCT/AU2010/000464 patent/WO2010121320A1/en active Application Filing
- 2010-04-23 CN CN201610051677.7A patent/CN105663045A/zh active Pending
- 2010-04-23 MY MYPI2011005119A patent/MY159098A/en unknown
- 2010-04-23 IL IL254370A patent/IL254370B2/en unknown
- 2010-04-23 JP JP2012506282A patent/JP6141012B2/ja active Active
- 2010-04-23 AU AU2010239159A patent/AU2010239159C1/en active Active
-
2011
- 2011-10-23 IL IL215867A patent/IL215867A0/en unknown
- 2011-11-23 CO CO11160575A patent/CO6470805A2/es active IP Right Grant
- 2011-11-24 ZA ZA2011/08651A patent/ZA201108651B/en unknown
-
2015
- 2015-04-27 US US14/697,497 patent/US20150306556A1/en not_active Abandoned
-
2017
- 2017-01-05 JP JP2017000459A patent/JP6534689B2/ja active Active
- 2017-05-17 US US15/598,248 patent/US20170320030A1/en not_active Abandoned
-
2018
- 2018-02-23 US US15/904,051 patent/US20180243707A1/en not_active Abandoned
-
2020
- 2020-01-27 US US16/773,959 patent/US20200316546A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY159098A (en) | Production of encapsulated nanoparticles at high volume fractions | |
PH12015501780A1 (en) | Production of encapsulated nanoparticles at commercial scale | |
PH12015501782A1 (en) | Method for production of commercial nanoparticles and microparticle powders | |
PH12015500301B1 (en) | A novel formulation of diclofenac | |
PH12016500746A1 (en) | A novel formulation of meloxicam | |
TN2011000544A1 (en) | A novel formualtion of indomethacin | |
TN2011000536A1 (en) | A novel formulation of naproxen | |
MX360019B (es) | Una formulación novedosa de metaxalona. | |
PH12015501811A1 (en) | Production of encapsulated nanoparticles at high volume fractions | |
NZ710321A (en) | Production of encapsulated nanoparticles at high volume fractions | |
AU2014208310B2 (en) | A Novel Formulation of Diclofenac | |
TH125552B (th) | การผลิตของอนุภาคนาโนที่ถูกกักเก็บที่สัดส่วนเชิงปริมาตรสูง |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |